Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial of Neuroskin Forte for dry skin relief in psoriasis and atopic dermatitis (eczema) was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuroskin Forte

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Psoriasis, Eczema | Phase 2 | Status: TERMINATED | Results posted: 2017-04-25